Search

Search Constraints

You searched for: Author/Creator Anderson, Kenneth C.

Search Results

1. A 3D‐Bioprinted Multiple Myeloma Model (Adv. Healthcare Mater. 7/2022). Issue 7 (6th April 2022)

2. A 3D‐Bioprinted Multiple Myeloma Model. Issue 7 (23rd September 2021)

3. A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells. (20th April 2016)

4. A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma. (8th May 2018)

5. A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma. (3rd May 2017)

6. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups. Issue 12 (December 2018)

7. Bone marrow biopsy in low‐risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group. Issue 5 (6th March 2019)

8. Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1. (20th January 2017)

9. Clinical utility of C‐terminal telopeptide of type 1 collagen in multiple myeloma. (20th January 2016)

10. Clonal architecture of CXCR4 WHIM‐like mutations in Waldenström Macroglobulinaemia. (13th December 2015)